Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

NCT03324542 · clinicaltrials.gov ↗

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

AMD

Interventions

DRUG: Aflibercept [Eylea]

Sponsor

Changhua Christian Hospital